Afatinib Treatment for Her-2 Amplified Metastatic Colorectal Cancer Based on Patient-Derived Xenograft Models and Next Generation Sequencing

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1529120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Clinical Cancer Research
Cancer ResearchOncology
2014English

Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma With Response to Lapatinib Treatment

Case Reports in Oncological Medicine
Oncology
2015English

Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research

Cancer and Metastasis Reviews
Cancer ResearchOncology
2016English

Establishment of Lung Cancer Patient-Derived Xenograft Models and Primary Cell Lines for Lung Cancer Study

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Current Colorectal Cancer Reports
HepatologyOncologyGastroenterology
2014English

Expression Profile Analysis of Long Noncoding RNA in HER-2-enriched Subtype Breast Cancer by Next-Generation Sequencing and Bioinformatics

OncoTargets and Therapy
OncologyPharmacology
2016English

Next-Generation Sequencing in Thyroid Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Next-Generation Sequencing Reveals Lymph Node Metastasis Associated Genetic Markers in Colorectal Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy